|Articles|October 7, 2020

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter 10-07-2020
  • Volume 15
  • Issue 10

Natoli Installs Tablet Press at its New Research and Training Facility

Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.

Natoli Engineering installed its Natoli NP-RD30 rotary tablet press in its new research and training facility, the Diosna ProcessLab in Osnabrück, Germany. The lab was completed in April 2020 and is built for research and formulation trials as well as virtual and in-person training classes. With the tablet press, the lab offers complete production of tablets from powder mixing, granulation, final blending, and tableting to coating.

The tablet press combines the design of a full-scale production press with the analytical capabilities of an R&D machine. Designed to tackle formulation and scale-up challenges, the tablet press comes equipped with a 21” HMI touchscreen, a USB port for data transfer, rolling casters, a dual vacuum system, a built-in calibration tool, upper and lower punch seals, powder recirculation system, and a self-adjusting lower punch with a push button feature, a Sept. 9, 2020 company press release said. The fast-fill cam design produces a vacuum to help with die filling for tablet weights while featuring diameter pre- and main compression rollers, independent overload, ejection, and take-off force monitoring.

Source: Natoli​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.